To gain a better understanding of how IL-36γ might impact the pathogenesis of obesity and metabolic diseases, we examined the expression levels of IL36G and its main receptor, IL36R, in metabolically active tissues. This evidence concerns the gene IL1RL2 and metabolic disease.